Kennedy Paul F. 4
4 · IVAX DIAGNOSTICS INC · Filed Mar 31, 2009
Insider Transaction Report
Form 4
Debregeas Patrice
Director10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2009-03-27$0.70/sh−1,500,000$1,050,000→ 2,800,000 total - Purchase
Common Stock, $0.01 par value
2009-03-27$0.70/sh+1,500,000$1,050,000→ 14,350,000 total
Holdings
- 2,850,000(indirect: By LLC)
Common Stock, $0.01 par value
- 2,850,000
Common Stock, $0.01 par value
- 14,350,000(indirect: By Debregeas & Associes Pharma SAS)
Common Stock, $0.01 par value
Footnotes (5)
- [F1]On March 27, 2009, Debregeas & Associes Pharma SAS and Paul F. Kennedy entered into a stock purchase agreement, pursuant to which Debregeas & Associes Pharma SAS agreed to purchase from Paul F. Kennedy 1,500,000 shares of the issuer's common stock at a purchase price of $0.70 per share.
- [F2]These shares of the issuer's common stock are directly owned solely by Debregeas & Associes Pharma SAS and indirectly owned by Patrice Debregeas, who may be deemed to control Debregeas & Associes Pharma SAS.
- [F3]These shares of the issuer's common stock are directly owned solely by Paul F. Kennedy.
- [F4]These shares of the issuer's common stock are directly owned solely by Umbria LLC and indirectly owned by Paul F. Kennedy, the sole equity owner of Umbria LLC.
- [F5]Debregeas & Associes Pharma SAS, Patrice Debregeas, Paul F. Kennedy and Umbria LLC comprise a "group" under Section 13(d) of the Securities Exchange Act of 1934, as amended, with respect to their ownership of shares of the issuer's common stock.